Canopy Growth Corporation (CGC), a Healthcare Drug Manufacturers—Specialty & Generic business, saw its stock trade 19.67 common shares, decrease against to its 10-day trading volume of 6.33M.
Canopy Growth Corporation (CGC) stock is quoted at $19.67, down -1.5 cents or -7.09% on the day. Based on this we can see some traders are either waiting on the sidelines to get involved or perhaps some are taking losses.
Gross Profit is $88.93M .
Canopy Growth Corporation (CGC) will release its financial results for the third quarter fiscal 2020 ended December 31, 2019 before financial markets open on February 14, 2020 .
Following the release of its third quarter fiscal 2020 financial results, Canopy Growth will host an audio webcast with David Klein , CEO and Mike Lee , EVP & CFO at 10:00 AM Eastern Time on February 14, 2020.
A live audio webcast will be available at:
A replay of the call will be accessible by webcast until 11:59 PM ET on May 14, 2020 at:
Canopy Growth Corporation (CGC) Technical Details:
The average 10-day trading volume of Canopy Growth Corporation (CGC) is 6.33M compared to 9.42M over the last 3 months which indicates decrease in trading activity. At the time of writing, Canopy Growth Corporation (CGC) has a 50-day moving average of $21.76 and a 200-day moving average of $23.44. These moving averages are popular technical figures that investors use to analyze price trends of Canopy Growth Corporation (CGC).
Approximately 21.31% of the shares of the company are sold short from investors betting the shares may trade lower. The Canopy Growth Corporation (CGC) stock is indicating its 5.12% to 6.94% more volatile than the overall market.
Technically, CGC’s short term support levels are around $20.29, $19.59 and $18.64 on the downside. CGCs short term resistance levels are $28.82, $28.25 and $25.45 on the upside.
Based on technical analysis, CGC has short term rating of Neutral (0.01), Intermediate rating of Neutral (0.02) and the long-term rating of Neutral (0.22) giving it an overall rating of Neutral (0.08).
CGC is trading 40.99% off its 52 week low at $13.81 and -63.08% off its 52 week high of $52.74. Performance wise, CGC stock has recently shown investors -9.34% decrease in a week, 6.92% an increase in a month and 6.60% an increase in the past quarter.
More importantly, Canopy Growth Corporation (CGC) has shown a return of 0.38% since the beginning of the year.
Canopy Growth Corporation (CGC) Key Data:
Canopy Growth Corporation (CGC) is a mid cap company with a market cap value of $6.847B.
On Nov-20-19 BofA/Merrill Upgrade CGC as Neutral → Buy, On Dec-12-19 Cantor Fitzgerald Reiterated CGC as Neutral at $18.90 → $27 and on Jan-28-20 BMO Capital Markets Upgrade CGC as Market Perform → Outperform.
There are currently 218.80M shares in the float and 348.33M shares outstanding. There are 21.31% shares short in CGCs float.
The industry rank for Canopy Growth Corporation (CGC) is 74 out of 255 ranking it at the Top 29% .
Canopy Growth Corporation (CGC) Fundamentals Statistics:
CGC last 2 years revenues have increased from $226,341 to $344,193 showing an uptrend.
The growth rate on CGC this year is 144.03 compared to an industry 2.70. However, CGCs next year’s growth rate is -76.03 compared to an industry 21.50.
The book value per share (mrq) is 5.29 and cash per share (mrq) is -. Giving them a price/book (mrq) of 1.73 compared to an industry of 4.05 and CGCs price/cash flow (mrfy) is NA compared to an industry of 19.75.
CGC fundamental ratios shows an EPS growth vs. previous year -3.88 and EPS growth vs. previous quarter -0.36.
About Canopy Growth Corporation (CGC):
Canopy Growth Corporation is a cannabis company. It offers dry cannabis and oil products primarily under the Tweed and Bedrocan brands. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.